The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity (CROSBI ID 114050)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Sikirić, Predrag ; Gyires, K. ; Seiwerth, Sven ; Grabarević, Željko ; Ručman, Rudolf ; Petek, Marijan ; Rotkvić, Ivo ; Turković, Branko ; Udovičić, Ivan ; Jagić, Vjekoslav ; Mildner, Boris ; Duvnjak, Marko ; Danilović, Žarko ; Kolega, Marko ; Sallmani, Ahmet ; Đačić, Sanja ; Hanzevački, Milan ; Lang, Nada ; Šimičević, Velimir ; Veljača, Marija ; Orihovac, V. ; Banić, Marko ; Brkić, Tomislav ; Buljat, Gojko ; Perović, Darko ; Miše, Stjepan ; Marović, Anton ; Šeparović, Jadranka ; Ćorić, Vedran ; Cviko, Aida ; Bura, Miljenko
engleski
The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity
The anti-nociceptive effects of a newly synthesized pentadecapeptide coded BPC 157 (an essential fragment of new organoprotective gastric juice peptide BPC) was evaluated in comparison with aspirin and morphine reference standards, in various experimental models of indirect/direct nociception and neurotoxicity: writhing (acetic acid/magnesium sulphate), tail pinching, hot-plate, and capsaicin applicaion. BPC 157 administered either in the ng or ug per kg range, intraperitoneally, significantly reduced the reactions in the writhing (inflammatory and non-inflammatory, prostaglandin-dependent and independent) and tail pinching tests. In the hot-plate test, unlike morphine, BPC 157 strongly reduced capsaicin-allodynia, either given as pretreatment or once daily for 14 days after the capsaicin injection. This reduction in capsaicin's effect could not be obtained when BPC 157 was applied in the presence of established capsaicin-somatosensory neuron degeneration (application only on the 14th day after capsaicin), so it is possible that hte effects of BPC 157 could be related specifically to the integrity of capsaicin-sensitive somatosensory neurons and their protection (e.g. primary afferent neurons having small-diameter somata and unmyelinated (C-) or thinly myelinated (Adelta-)fibres.
pentadecapeptide BPC 157 ; essential fragment of organoprotective gastric juice peptide BPC ; writhing (acetic acid/magnesium sulphate) ; tail pincing test ; hot-plate test ; inflammatory /nin-inflammatory ; indirect/direct nocicepetion ; capsaicin ; allodynia ; ca
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano